Exponent, Inc. (NASDAQ:EXPO) Stake Raised by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. boosted its stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 2.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 441,646 shares of the business services provider's stock after purchasing an additional 8,501 shares during the period. Envestnet Asset Management Inc. owned approximately 0.87% of Exponent worth $35,800,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Atala Financial Inc acquired a new stake in shares of Exponent during the fourth quarter valued at about $25,000. Whipplewood Advisors LLC grew its stake in shares of Exponent by 5,333.3% during the first quarter. Whipplewood Advisors LLC now owns 326 shares of the business services provider's stock valued at $26,000 after acquiring an additional 320 shares in the last quarter. Brown Brothers Harriman & Co. acquired a new stake in shares of Exponent during the fourth quarter valued at about $50,000. UMB Bank n.a. grew its stake in shares of Exponent by 859.1% during the first quarter. UMB Bank n.a. now owns 633 shares of the business services provider's stock valued at $51,000 after acquiring an additional 567 shares in the last quarter. Finally, Johnson Financial Group Inc. acquired a new stake in shares of Exponent during the fourth quarter valued at about $59,000. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Exponent Price Performance

NASDAQ:EXPO traded up $1.14 during mid-day trading on Thursday, reaching $74.06. The stock had a trading volume of 298,425 shares, compared to its average volume of 263,232. The company has a market capitalization of $3.76 billion, a price-to-earnings ratio of 36.13 and a beta of 0.90. Exponent, Inc. has a 1-year low of $71.72 and a 1-year high of $115.75. The stock's 50 day simple moving average is $76.34 and its two-hundred day simple moving average is $81.68.

Exponent (NASDAQ:EXPO - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. The business had revenue of $137.44 million during the quarter, compared to the consensus estimate of $134.63 million. Exponent had a return on equity of 25.33% and a net margin of 18.87%. The company's revenue for the quarter was up .2% compared to the same quarter last year. During the same period last year, the firm earned $0.59 earnings per share. Sell-side analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current fiscal year.

Exponent Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, June 20th. Investors of record on Friday, June 6th were paid a $0.30 dividend. The ex-dividend date was Friday, June 6th. This represents a $1.20 dividend on an annualized basis and a yield of 1.62%. Exponent's dividend payout ratio (DPR) is 58.54%.

Insiders Place Their Bets

In other Exponent news, VP John Pye sold 2,000 shares of the firm's stock in a transaction dated Friday, May 23rd. The shares were sold at an average price of $76.32, for a total value of $152,640.00. Following the transaction, the vice president owned 29,204 shares of the company's stock, valued at $2,228,849.28. This trade represents a 6.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Joseph Rakow sold 1,573 shares of the firm's stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $77.72, for a total transaction of $122,253.56. The disclosure for this sale can be found here. Insiders have sold 6,267 shares of company stock valued at $489,120 over the last quarter. Insiders own 1.60% of the company's stock.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.